摘要
目的:探讨分析黄葵胶囊联合ACEI降低慢性肾小球肾炎蛋白尿的临床疗效。方法:将慢性肾小球肾炎120例患者随机分为研究组和对照组,每组60例。对照组患者使用单纯ACEI治疗,研究组患者采用黄葵胶囊联合ACEI治疗,比较两组患者的疗效,尤其是使用的药物对降低慢性肾小球肾炎蛋白尿的临床效果。结果:研究组60例患者经过治疗后显效42例,有效15例,总有效率为95.00%;对照组60例患者经过治疗后显效28例,有效16例,总有效率为73.33%。研究组临床疗效明显高于对照组,差异有统计学意义(P<0.05)。治疗后研究组和对照组的尿蛋白数值均有所降低,研究组尿蛋白的降低幅度显著大于对照组,差异有统计学意义(P<0.05)。结论:采用黄葵胶囊联合ACEI降低慢性肾小球肾炎蛋白尿的临床疗效十分显著,无不良反应,值得在临床上推广使用。
Objective：To explore the clinical effect of Huangkui Capsule combined with ACEI on reducing proteinuria of chronic glomerulonephritis. Method：120 cases of chronic glomerulonephritis were randomly divided into study group（n=60） and control group（n=60）.The control group was treated with ACEI alone,the study group was treated with Huangkui Capsule combined with ACEI.The effects,especially the clinical effects of reducing proteinuria of two groups were compared.Result：The total efficiency rate of the study group was 95.00%,and the control group was 73.33%.The effect was better in study group than that in control group,the difference was statistically significant（P〈0.05）.Urine protein was reduced in both groups,but it decreased significantly in study group than that in control group,the difference was statistically significant（P〈0.05）.Conclusion：The effect of Huangkui Capsule combined with ACEI on reducing proteinuria of chronic glomerulonephritis is significant,without adverse reaction,and is worth promoting in clinical use.
出处
《中外医学研究》
2014年第19期30-32,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
